| Authors: |
Leongamornlert D; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom., Gutiérrez-Abril J; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Lee S; Department of Haematology, University College London (UCL) Cancer Institute, London, United Kingdom., Barretta E; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Creasey T; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Gundem G; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Levine MF; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Arango-Ossa JE; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Liosis K; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Medina-Martinez JS; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Zuborne Alapi K; Department of Haematology, University College London (UCL) Cancer Institute, London, United Kingdom., Kirkwood AA; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom., Clifton-Hadley L; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom., Patrick P; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom., Jones D; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom., O'Neill L; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom., Butler AP; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom., Harrison CJ; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Campbell P; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom., Patel B; Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University, London, United Kingdom., Moorman AV; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Fielding AK; Department of Haematology, University College London (UCL) Cancer Institute, London, United Kingdom., Papaemmanuil E; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. |
